Current and evolving practices of carbohydrate antigens in gastric cancer: a narrative review
Authors:
Open Access
- 1 June 2025
- journal article
- review article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 14 (6) , 3860-3873
Abstract
Background and Objective: Carbohydrate antigens (CAs) are of great significance in various aspects of gastric cancer (GC). As new members of the family of CAs continue to be discovered, there is a growing focus on their role as therapeutic targets. The comprehensive review aims to provide an in-depth analysis of the current and evolving utilization of CAs in GC, offering valuable insights on the role of CAs as therapeutic targets or biomarkers for GC patients. Methods: A detailed narrative review of the most recent literature was conducted to assess the current use and advancements of CAs in GC. PubMed database was being examined and the last run was on 8 June 2024. Key Content and Findings: This article traces the discovery and biological properties of CAs and their role in GC clinical practice. CAs not only serve a crucial clinical function in the diagnosis, therapy monitoring, metastatic evaluation, and prognosis of GC, but they also improve biological performance when paired with other biomarkers. New CAs, like truncated O-glycans, gangliosides, globo-series glycan, and Lewis antigens, significantly influence GC progression, metastatic infiltration, and individual susceptibility. Moreover, these antigens exhibit unique potential in GC treatment, offering new approaches and insights for GC treatment. Conclusions: The use of CAs in GC diagnosis, prognosis, monitoring, and targeting therapy is beneficial. With the ongoing advancement of detection methodologies and technologies, challenges related to the sensitivity and specificity of CAs detection are anticipated to be progressively and effectively addressed. This will make its application in GC more widespread and effective.Keywords
This publication has 106 references indexed in Scilit:
- The chemistry and immunochemistry of blood group A, B, H, and Lewis antigens: Past, present and futureGlycoconjugate Journal, 2000
- Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in manProceedings of the National Academy of Sciences, 1999
- Glycosylation features of gastric carcinoma initiation and progression. A review with emphasis on simple mucin-type carbohydrates and histo-blood group antigens of the Lewis systemEuropean Journal Of Cancer Prevention, 1994
- CA72–4: A new tumour marker for gastric cancerBritish Journal of Surgery, 1990
- Aberrant Glycosylation In Tumors And Tumor-Associated Carbohydrate Antigens1989
- PREPARATION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES DIRECTED TO THE TUMOR-ASSOCIATED O-LINKED SIALOSYL-2-]6 ALPHA-N-ACETYLGALACTOSAMINYL (SIALOSYL-TN)EPITOPE1988
- Tn, a carcinoma-associated antigen, reacts with anti-Tn of normal human seraCancer, 1985
- New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3.Journal of Biological Chemistry, 1983
- NEUTRAL FUCOLIPIDS AND FUCOGANGLIOSIDES OF RAT HEPATOMA HTC AND H35 CELLS, RAT-LIVER, AND HEPATOCYTES1979
- Blood group MN antigens and precursors in normal and malignant human breast glandular tissue.1975